U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C16H17N9O5S2
Molecular Weight 479.493
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of CEFTERAM

SMILES

[H][C@]12SCC(CN3N=NC(C)=N3)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C4=CSC(N)=N4)C(O)=O

InChI

InChIKey=XSPUSVIQHBDITA-RKYNPMAHSA-N
InChI=1S/C16H17N9O5S2/c1-6-20-23-24(21-6)3-7-4-31-14-10(13(27)25(14)11(7)15(28)29)19-12(26)9(22-30-2)8-5-32-16(17)18-8/h5,10,14H,3-4H2,1-2H3,(H2,17,18)(H,19,26)(H,28,29)/b22-9-/t10-,14-/m1/s1

HIDE SMILES / InChI

Molecular Formula C16H17N9O5S2
Molecular Weight 479.493
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 1
Optical Activity UNSPECIFIED

Cefteram is a semisynthetic cephalosporin formulated for oral administration as the prodrug ester, cefteram pivoxil. The mechanism of action of cefteram is inhibition of bacterial cell wall synthesis. Cefteram exerts its bactericidal activity by strongly binding to penicillin-binding protein (PBP) 3, 1A, and 1Bs. The drug is available in Japan and is used for the treatment of bacterial infections.

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
TOMIRON

Approved Use

To treat pharyngitis/laryngitis, tonsillitis (including peritonsillitis and peritonsillar abscess), acute bronchitis, pneumonia, and secondary infections in chronic respiratory lesion; cystitis, pyelonephritis and urethritis; bartholinitis, intrauterine infection and uterine adnexitis; otitis media and sinusitis; periodontitis, pericoronitis and gnathitis
PubMed

PubMed

TitleDatePubMed
In vitro activity of Ro 19-5247 (T-2525) and interpretive criteria for disk diffusion susceptibility testing.
1987 Jul
In vitro activity of Ro 15-8074, Ro 19-5247, A-56268, and roxithromycin (RU 28965) against Neisseria gonorrhoeae and Chlamydia trachomatis.
1987 Mar
Preliminary antimicrobial susceptibility interpretive criteria for cefetamet (Ro 15-8074) and cefteram (Ro 19-5247) disk tests.
1987 Sep
Patents

Sample Use Guides

The usual adult dosage for oral use is 150 − 600 mg (potency) of cefteram pivoxil daily in 3 divided doses after meals.
Route of Administration: Oral
The activity of cefteram was compared with that of other P-lactams against a total of 491 bacterial strains. The drug was highly active (MIC for 90% of the strains tested [MIC90] < 2 ug/ml) against the majority of the members of the family Enterobacteriaceae, Haemophilus influenzae, Neisseria spp., and Streptococcuspneumoniae, being at least 16-fold more active than cephalexin and 8-fold more active than cefuroxime. There was no activity against Pseudomonas aeruginosa, Enterobacter sp., and Citrobacter sp. Staphylococcus aureus was moderately susceptible to cefteram (MIC90, 8 ug/ml).
Substance Class Chemical
Created
by admin
on Sat Dec 16 15:55:46 GMT 2023
Edited
by admin
on Sat Dec 16 15:55:46 GMT 2023
Record UNII
74CQ4Q3N63
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CEFTERAM
INN   MI   WHO-DD  
INN  
Official Name English
(+)-(6R,7R)-7-(2-(2-AMINO-4-THIAZOLYL)GLYOXYLAMIDO)-3-((5-METHYL-2H-TETRAZOL-2-YL)METHYL)-8-OXO-5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, 7(SUP 2)-(Z)-(O-METHYLOXIME)
Common Name English
CEFTERAM [MI]
Common Name English
CEFTERAM [JAN]
Common Name English
cefteram [INN]
Common Name English
Cefteram [WHO-DD]
Common Name English
RO 19-5247
Code English
CEFTERAM PIVOXIL [JAN]
Common Name English
Classification Tree Code System Code
WHO-ATC J01DD18
Created by admin on Sat Dec 16 15:55:47 GMT 2023 , Edited by admin on Sat Dec 16 15:55:47 GMT 2023
NCI_THESAURUS C357
Created by admin on Sat Dec 16 15:55:47 GMT 2023 , Edited by admin on Sat Dec 16 15:55:47 GMT 2023
Code System Code Type Description
PUBCHEM
6537431
Created by admin on Sat Dec 16 15:55:47 GMT 2023 , Edited by admin on Sat Dec 16 15:55:47 GMT 2023
PRIMARY
EVMPD
SUB07423MIG
Created by admin on Sat Dec 16 15:55:47 GMT 2023 , Edited by admin on Sat Dec 16 15:55:47 GMT 2023
PRIMARY
CAS
82547-58-8
Created by admin on Sat Dec 16 15:55:47 GMT 2023 , Edited by admin on Sat Dec 16 15:55:47 GMT 2023
PRIMARY
SMS_ID
100000081833
Created by admin on Sat Dec 16 15:55:47 GMT 2023 , Edited by admin on Sat Dec 16 15:55:47 GMT 2023
PRIMARY
ChEMBL
CHEMBL2105953
Created by admin on Sat Dec 16 15:55:47 GMT 2023 , Edited by admin on Sat Dec 16 15:55:47 GMT 2023
PRIMARY
CHEBI
135776
Created by admin on Sat Dec 16 15:55:47 GMT 2023 , Edited by admin on Sat Dec 16 15:55:47 GMT 2023
PRIMARY
DRUG CENTRAL
3076
Created by admin on Sat Dec 16 15:55:47 GMT 2023 , Edited by admin on Sat Dec 16 15:55:47 GMT 2023
PRIMARY
FDA UNII
74CQ4Q3N63
Created by admin on Sat Dec 16 15:55:47 GMT 2023 , Edited by admin on Sat Dec 16 15:55:47 GMT 2023
PRIMARY
NCI_THESAURUS
C81035
Created by admin on Sat Dec 16 15:55:47 GMT 2023 , Edited by admin on Sat Dec 16 15:55:47 GMT 2023
PRIMARY
MERCK INDEX
m3219
Created by admin on Sat Dec 16 15:55:47 GMT 2023 , Edited by admin on Sat Dec 16 15:55:47 GMT 2023
PRIMARY Merck Index
INN
5947
Created by admin on Sat Dec 16 15:55:47 GMT 2023 , Edited by admin on Sat Dec 16 15:55:47 GMT 2023
PRIMARY
EPA CompTox
DTXSID7048821
Created by admin on Sat Dec 16 15:55:47 GMT 2023 , Edited by admin on Sat Dec 16 15:55:47 GMT 2023
PRIMARY
WIKIPEDIA
Cefteram
Created by admin on Sat Dec 16 15:55:47 GMT 2023 , Edited by admin on Sat Dec 16 15:55:47 GMT 2023
PRIMARY
Related Record Type Details
PRODRUG -> METABOLITE ACTIVE
Related Record Type Details
ACTIVE MOIETY